Quantum BioPharma Ltd.
QNTM
$3.24
-$0.20-5.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.86M | 4.56M | 2.36M | 1.08M | 1.53M |
| Total Receivables | 107.60K | 208.50K | 231.10K | 2.94M | 3.23M |
| Inventory | 53.00K | 51.50K | 52.10K | 77.60K | 76.90K |
| Prepaid Expenses | 55.30K | 76.20K | 15.30K | 39.30K | 425.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.89M | 5.47M | 3.82M | 5.21M | 5.08M |
| Total Current Assets | 9.96M | 10.37M | 6.48M | 9.34M | 10.34M |
|
|
|||||
| Total Current Assets | 9.96M | 10.37M | 6.48M | 9.34M | 10.34M |
| Net Property, Plant & Equipment | 125.90K | 147.50K | 169.30K | 190.80K | 228.20K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.30M | 4.41M | 4.51M | 4.62M | 4.73M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 14.39M | 14.93M | 11.16M | 14.15M | 15.30M |
|
|
|||||
| Total Accounts Payable | 2.08M | 1.98M | 1.98M | 2.61M | 1.87M |
| Total Accrued Expenses | 1.30M | 1.61M | 2.20M | 1.48M | 1.32M |
| Short-term Debt | 300.50K | 300.50K | 1.30M | 1.98M | 1.94M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 662.80K | 569.50K | 575.70K | 581.80K | 320.60K |
| Total Finance Division Other Current Liabilities | 3.95M | 11.88M | -- | 1.80K | 7.79M |
| Total Other Current Liabilities | 3.95M | 11.88M | -- | 1.80K | 7.79M |
| Total Current Liabilities | 8.30M | 16.35M | 6.06M | 6.65M | 13.25M |
|
|
|||||
| Total Current Liabilities | 8.30M | 16.35M | 6.06M | 6.65M | 13.25M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 300.50K | 300.50K | 1.30M | 1.98M | 1.94M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.30M | 16.35M | 6.06M | 6.65M | 13.25M |
|
|
|||||
| Common Stock & APIC | 222.78M | 212.23M | 205.11M | 202.61M | 192.54M |
| Retained Earnings | -215.10M | -211.85M | -198.29M | -195.26M | -189.94M |
| Treasury Stock & Other | 269.80K | 214.50K | 101.50K | 1.30M | 1.16M |
| Total Common Equity | 7.95M | 595.20K | 6.92M | 8.65M | 3.76M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.95M | 595.20K | 6.92M | 8.65M | 3.76M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.86M | -2.02M | -1.82M | -1.15M | -1.72M |
| Total Equity | 6.09M | -1.42M | 5.10M | 7.51M | 2.05M |
|
|
|||||